NEW
YORK, May 14, 2024 /PRNewswire/ -- The
global flow cytometry market size is
estimated to grow by USD 6038.44
million from 2023-2027, according to Technavio. The market
is estimated to grow at a CAGR of about 13.12% during the
forecast period.
For more insights on the forecast market size and
historic data (2017 - 2021) - Download
Free sample report in a minutes
Forecast
period
|
2023-2027
|
Base Year
|
2022
|
Historic
Data
|
2017 - 2021
|
Segment
Covered
|
Product (Reagents and
consumables, Instruments, and Others ), End-user (Pharmaceutical
industry, Health and diagnostic centers, and Others ), and
Geography (North America, Europe, Asia, and Rest of World
(ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Abbott Laboratories,
Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd.,
Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek
Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc.,
Miltenyi Biotec B.V. And Co. KG, Mindray Bio medical Electronics
Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip
Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp.,
Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and
Union Biometrica Inc.
|
Key Market Trends Fueling Growth
Flow cytometry, a crucial technology in life science and
biopharmaceutical research, has witnessed significant automation
over the past few decades. From manual sample preparation and
loading to advanced instruments for sample preparation, loading,
and storage, the market has seen substantial growth. These digital
devices reduce human intervention, offer seamless integration with
other processes, and decrease processing time and supervision. Key
applications include multiparametric data analysis, stem cell
cultures, and fluorescent-labeled antibodies. Flow cytometry
services cover various sectors like cancer, HIV, drug discovery,
and immune disorders. Innovations include microfluidic flow
cytometry, liquid handling robotics, and cellular diagnostics.
Fluorochrome combinations and flow cytometric services are
essential components of this market. PCR and antibody-based testing
are additional applications.
Market Challenges
* Flow cytometers are increasingly utilized in drug
discovery and development due to their analytical capabilities.
* The high cost of flow cytometer instruments is a significant
challenge to market growth.
* Costs vary based on type and brand, with an average price ranging
from $100,200 to $500,200 per unit.
* Additional expenses include reagents, markers, consumables, and
software support.
* The average cost of a flow cytometry kit is approximately
$220-$230.
* Large initial investment required for procurement, setup, and
calibration.
* Instruments have a useful life of six to eight years, with a low
probability of replacement within the first five years.
* Innovation in product features, digitization, and accessories
leads to faster obsolescence and shorter replacement cycles.
* Total ownership cost is high, particularly in healthcare and
pharmaceutical sectors.
* Cost of flow cytometer instruments, along with additional
components and maintenance, may hinder market growth.
Research report provides comprehensive data on
impact of trend, driver and challenges - Buy
Report
Segment Overview
This flow cytometry market report extensively covers market
segmentation by
- Product
- 1.1 Reagents and consumables
- 1.2 Instruments
- 1.3 Others
- End-user
- 2.1 Pharmaceutical industry
- 2.2 Health and diagnostic centers
- 2.3 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Reagents and consumables- The flow cytometry
market segment encompasses a range of products essential for this
technique, including reagents and consumables, digital signal
processing instruments, data analysis solutions, software, and
accessories. These products cater to various applications in the
healthcare sector, particularly in the diagnosis and monitoring of
infectious diseases such as AIDS and tuberculosis, as well as
sexually transmitted diseases. In drug development activities,
cell-based flow cytometry and bead-based assays are employed for
stem cell cultures and the analysis of multiparametric data. Flow
cytometers, fluorescent-labeled antibodies, and fluorescent-labeled
compounds are integral components of this market, enabling the
detection of conditions like cancer and HIV. Control parameters and
flow cytometry services are also crucial for ensuring accurate
results. Flow cytometry innovators and contract service providers
offer flow cytometry analysis, techniques such as Western blotting
and immunohistochemistry, and microscopy services to cater to the
growing demand for these instruments in clinical testing labs. The
market is driven by the increasing prevalence of autoimmune
disorders, leukemia, lymphoma, and other diseases, as well as the
need for rapid point-of-care diagnostics.
For more information on market segmentation with geographical
analysis including forecast (2023-2027) and historic data (2017 -
2021) - Download a Sample Report
Research Analysis
The Flow Cytometry Market encompasses the use of multiparametric
data analysis solutions for stem cell research, including the
application of fluorescent-labeled antibodies and compounds in flow
cytometry services. Flow cytometry technique is a crucial tool in
life science, biotechnology, and biopharmaceutical research
activities, enabling the analysis of various cell types and their
characteristics. Flow cytometer instruments are employed in the
diagnosis and monitoring of autoimmune disorders, infectious
diseases such as AIDS, and cancer, as well as immunodeficiency
disorders. Microfluidic flow cytometry and PCR are advanced
technologies used in this field, while antibody-based testing is a
common application. Western blotting and immunohistochemistry,
along with microscopy, serve as complementary techniques for
further investigation. Control parameters ensure accurate and
reliable data analysis.
Market Research Overview
The Flow Cytometry Market refers to the global industry
dedicated to the production, sale, and use of flow cytometry
instruments and related consumables. These technologies enable the
analysis of cellular components in various fields, including
immunology, hematology, and research. The market is driven by
factors such as increasing research and development activities,
rising demand for personalized medicine, and technological
advancements. Flow cytometry techniques offer high-speed analysis,
multi-parameter detection, and the ability to sort cells based on
specific characteristics. The market encompasses various
components, including instruments, reagents, and software, and
serves a diverse range of end-users, including academic and
research institutions, hospitals, and pharmaceutical and
biotechnology companies.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
-
- Reagents And Consumables
- Instruments
- Others
- End-user
-
- Pharmaceutical Industry
- Health And Diagnostic Centers
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/flow-cytometry-market-size-is-set-to-grow-by-usd-6038-44-million-from-2023-2027--increasing-expenditure-on-r-and-d-to-boost-the-market-growth-technavio-302144968.html
SOURCE Technavio